Vascular & Endovascular Highlights: ISC 2023 in review | TAVR patients with PAD face additional risks

News You Need to Know Today

Wednesday, February 15, 2023

Editor's Choice: Vascular & Endovascular

Abbott to acquire vascular disease specialists for $890M

Minnesota-based Cardiovascular Systems Inc. is perhaps best known for its atherectomy devices designed to treat PAD and CAD.

Abbott to acquire vascular disease specialists for $890M

Minnesota-based Cardiovascular Systems Inc. is perhaps best known for its atherectomy devices designed to treat PAD and CAD.

4 key takeaways from ISC 2023: AFib detection, improved stroke survival and more

Leading stroke specialists from all over the world gathered in Dallas for the 2023 International Stroke Conference. Catch up on some of the biggest stories that came out of the three-day event.

4 key takeaways from ISC 2023: AFib detection, improved stroke survival and more

Leading stroke specialists from all over the world gathered in Dallas for the 2023 International Stroke Conference. Catch up on some of the biggest stories that came out of the three-day event. 

TAVR and PAD: What cardiologists need to know

TAVR patients presenting with peripheral artery disease face significantly higher in-hospital risks, according to a new study published in Current Problems in Cardiology.

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.

TAVR and PAD: What cardiologists need to know

TAVR patients presenting with peripheral artery disease face significantly higher in-hospital risks, according to a new study published in Current Problems in Cardiology. 

A key step forward: Researchers ID the genes responsible for CAD

The team hopes its findings can lead to significant progress in the war against fatty plaques.

A heart attack is caused when one of the coronary arteries becomes blocked with a clot.

A key step forward: Researchers ID the genes responsible for CAD

The team hopes its findings can lead to significant progress in the war against fatty plaques.

Why more pulmonary embolism patients should be considered for surgery

The topic was explored at length in a new scientific statement presented at the 59th Annual Meeting of the Society of Thoracic Surgeons.

Why more pulmonary embolism patients should be considered for surgery

The topic was explored at length in a new scientific statement presented at the 59th Annual Meeting of the Society of Thoracic Surgeons.

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us | Unsubscribe from all | Privacy Policy

© Innovate Healthcare, a TriMed Media brand

Editor's Choice: Vascular & Endovascular

Recent Newsletters